These findings may reflect the protective effects of certain medications, such as ACE inhibitors, ARBs, and SGLT2 inhibitors, commonly prescribed in patients with hypertension, diabetes, and CAD. The gene discussed is SLC5A2; the disease is hypertensive disorder.